Life Sciences Law & Industry Report connects the dots among the many disciplines that make up the burgeoning life sciences industry, with biweekly updates on current regulatory, legislative,...
By John T. Aquino
Oct. 1 — A U.S. cancer institute asserted Sept. 25 in federal district court litigation that two U.S. researchers are co-inventors of cancer immunotherapy patents that are a result of the collegial exchanges of ideas and draft manuscripts with a Japanese researcher (Dana-Farber Cancer Institute, Inc. v. Ono Pharmaceutical Co., Ltd., D. Mass., No. 1:15-cv-13443, filed 9/25/15).
The complaint filed by Boston-based Dana-Farber Cancer Institute (DFCI) in the U.S. District Court for the District of Massachusetts contended that DFCI researcher Gordon J. Freeman and Clive R. Wood of the biotech the Genetics Institute, which is based in Cambridge, Mass., made contributions to five patents that show Tasuku Honjo and three colleagues at Kyoto University in Japan as the inventors. The DFCI asked the court to order the Patent and Trademark Office to correct the patents' inventorship to include Freeman and Wood.
As assignee of Freeman and Wood's patent rights, DFCI would become co-owner of the five patents: U.S. Patent Nos. 7,95,048; 8,168,179; 8,728,474; 9,067,999; and 9,073,994.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to email@example.com.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to firstname.lastname@example.org.
Put me on standing order
Notify me when new releases are available (no standing order will be created)